Neglected disease approvals up

chris.truelove The annual number of new drug approvals globally to treat neglected diseases has nearly doubled in recent years, with HIV/AIDS and malaria drugs accounting for 60 percent ...

Amgen basks in EU approval of Bayer/Onyx cancer drug Stivarga

Ryan McBride The European Commission has stamped an approval on Stivarga (a.k.a. regorafenib) for aggressive cases of colorectal cancer, marking a regulatory victory for Bayer Healthcare ...

China probes of Glaxo, Sanofi, others put big chill on key growth market

Eric Palmer The recent, and very public, Chinese investigation into bribery allegations against GlaxoSmithKline and others has doctors running scared, making it tough for everyone to ...

EC Approves Genzyme’s Aubagio for MS

mia.burns European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide)    CAMBRIDGE, Mass.–Aug. 30, 2013–(BUSINESS ...

Brain inflammation may be to blame for severe Parkinson’s

Emily Mullin The degree of neuroinflammation was significantly associated with more severe depression, fatigue and cognitive impairment even after taking into consideration other ...

Teva scraps depression program for Nuvigil after latest PhIII flop

John Carroll Teva ($ TEVA) today announced that it will dump its depression program for Nuvigil (armodafinil) after the treatment failed its latest Phase III test in a comparison against ...

Swiss regulators deny Apricus ED drug

Eric Palmer Swiss authorities have thrown cold water on Apricus Biosciences' Vitaros, a topically-applied cream for erectile dysfunction. The product has been approved in Ireland, ...

Compounding Problems: Anthem Restricts Coverage Of Some Compounded Meds

esilverman More fallout from the compounding controversy. Anthem Blue Cross Blue Shield, one of the nation’s largest insurers, has decided to end reimbursement of certain compounded ...

Takeda fills newly created CFO position

Alok Saboo FierceBiotech News

J&J follows up on pledge to add warning to Tylenol bottle caps

Eric Palmer The FDA has pushed makers of the nonaspirin pain reliever acetaminophen to do more to warn consumers about the dangers of the drug when taken in high doses. J&J is now ...

Unhealthy habits

chris.truelove I’ve recently gone back to the gym. Since the end of June to the time I am writing this, between working out at least five days a week and being more mindful of what ...

Icon Bioscience snags $15M in B round for eye therapies

Ryan McBride FierceBiotech News
Page 1 of 3812345...102030...Last »
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS